Introduction {#sec1-1}
============

Gastric ulcer is a defect in the gastric wall running through the entire mucosal thickness and penetrating the muscularis mucosae. A variety of factors has been implicated in the aetiology of gastric ulcers. These include humoral, genetic, neural, therapy induced (e.g. use of NSAIDs) and *Helicobacter pylori* infection \[[@ref1]\]. Gastric ulcer is precipitated by an imbalance between endogenous aggressive factors in the gastric lumen (such as hydrochloric acid, pepsin, refluxed bile, leukotrienes, reactive oxygen species) and cytoprotective factors; these include the function of the mucus-bicarbonate barrier, surface active phospholipids, prostaglandins, mucosal blood flow, cell renewal and migration, non-enzymatic and enzymatic antioxidants and some growth factors \[[@ref2]\]. It has a worldwide prevalence of about 5% \[[@ref3]\]. Nwokediuko et al. suggested that in Nigeria, there has been an increase in the prevalence of gastric ulcers over a 15-year period \[[@ref4]\].

The remodelling of the mucosal architecture involves an active process of filling the mucosal defect with proliferating and migrating epithelial cells and connective tissue components \[[@ref5]\]. This entails an intricate interaction of different tissues and cellular systems. Re-epithelization is an important process of ulcer healing in which epithelial cells migrate from the margin of the ulcer. Asides other factors responsible for ulcer healing, the Epidermal growth factor is cardinal for intensifying cell proliferation at the mucosa of the ulcer margin; it is also responsible for the restoration of the glandular structures by epithelial tubules originating from the mucosa adjacent to the ulcer crater base \[[@ref1]\]. Epidermal growth factor is a cell-surface protein primarily responsible for increased cell proliferation at the mucosa of the ulcer margin and re-epithelialization; hence its receptors are expressed as gastric glands dilate and the lining epithelial cells de-differentiate \[[@ref5]\].

Angiogenesis an important process in ulcer healing as it is essential for proliferation of endothelial cells as well as connective tissues involved in the formation of granulation tissue \[[@ref5]\]. Through the formation of a capillary network, angiogenesis in granulation tissue facilitates nutrient and oxygen delivery to the ulcer.

PECAM-1 is a protein involved in cell adhesion and angiogenesis which demonstrates the presence of endothelial cells and hence, evaluates the degree of angiogenesis. Connective tissue cells are supplied by granulation tissue to develop lamina propria and micro vessels which form micro vascular network in an ulcer scar tissue \[[@ref6]\].

The healing process depends on a progressive interaction between the epithelial part of the 'healing' zone at the ulcer margin and the connective tissue component (including microvessels) originating from the granulation tissue \[[@ref6]\].

*Musa paradisiaca* (*M. paradisiaca*) is a tropical plant which is called plantain or vegetable banana and has to be cooked to be edible. It is herbaceous (up to 9 m high) with oblong and fleshy fruits; 5-7cm long in wild form and longer in the cultivated varieties. In traditional folk medicine, different parts of this plant are used for numerous purposes. It is known to have varying medicinal properties \[[@ref7], [@ref8]\]. Studies have shown that the extract of unripe *M. paradisiaca* have high antioxidant activity which is attributed to the presence of phenols and phytochemicals which are potent antioxidants with free radical scavenging activities \[[@ref9]\]

Asides other phytochemicals, several flavonoids and related compounds have been isolated from the unripe pulp of plantain \[[@ref10]\]. A natural flavonoid from the unripe *MP* pulp, Leucocyanidin and the synthetic analogues were found to protect the gastric mucosa in aspirin-induced erosions in the rat by increasing gastric mucus thickness \[[@ref11]\]. Also, *MP* pulp powder showed significant antiulcerogenic activity in aspirin-, indomethacin-, phenylbutazone-, prednisolone-induced gastric ulcers in rats. The authors attributed the effect to increased mucosal thickness and increased \[3H\] thymidine incorporation into mucosal DNA that results in mucosal cellular proliferation and healing.

The major therapeutic approach for a gastric ulcer is the control of gastric acid secretion and re-inforcement of gastric mucosal production using antacids, H~2~-receptor blockers, proton pump inhibitors, anticholinergics and cytoprotective agents \[[@ref12]\]. The management of gastric ulcer is challenging because of the drawbacks with major therapies; these include high recurrence rate associated side effects from most drugs ranging from diarrhoea, itching and dizziness to arrhythmia, impotence, gynecomastia and hematopoietic changes \[[@ref13], [@ref14]\].

Recently, there has been an evolution to the use of alternative therapies and natural products especially those derived from plants as medicinal plants remain one of the promising sources of drugs and have produced propitious results in the treatment of various diseases including gastric ulcer.

Against the backdrop of previous studies and claims by traditional medical practitioners in South Western Nigeria on the efficacy of *MP* in the treatment of gastric ulcer; this work was initiated to verify if *MP* induces the expression of EGFR and PECAM-1 whose dynamic interaction is essential in gastric ulcer healing.

Materials and Methods {#sec1-2}
=====================

Plant Material {#sec2-1}
--------------

Mature, unripe fruits of *Musa paradisiaca* Linn (Musaceae) from a farmland were harvested in September 2014 between the hours of 16.00 and 17.00. The plant was identified by a taxonomist at the Department of Plant Science and Forestry, Ekiti State University, Ado-Ekiti, Nigeria (UHAE 2014/84).

The fruit pulp was cut into pieces, air-dried and pulverised using an electric grinder. 3kg of the powdered sample was extracted three times with 70% methanol (20% w/v) with continuous stirring using an Orbital shaker at room temperature for 48 hours each. This was filtered and the filtrate concentrated at 40 °C in a vacuum rotary evaporator under reduced pressure to obtain a dark brown extract of 98.51g. The crude extract was partitioned by solvent- solvent extraction with n-hexane, dichloromethane, ethyl acetate and n-butanol to obtain the flavonoid-rich fraction \[[@ref15]\]. The resulting flavonoid fraction weighing 28.28g was concentrated, freeze-dried in a vacuum freeze drier and stored in a desiccator until needed. The flavonoid fractions were subjected to phytochemical analysis using Shibata's reaction and Ferric chloride test \[[@ref16]\].

Animal Care and Management {#sec2-2}
--------------------------

Ninety healthy male Wistar rats weighing between 120-150 g used for this study were procured from the Animal House of the College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria. They were on a diet of standard rat pellets procured from Ladokun feeds, Ibadan and given tap water *ad libitum*. The rats were acclimatised for a week in plastic cages at the Animal Holding of the Department of Anatomy and Cell Biology, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria under standard laboratory conditions of natural light/dark cycle at room temperature and humidity. All animals were handled by the Guidelines for Animal research as detailed in the NIH Guidelines for the Care and Use of Laboratory Animals \[[@ref17]\].

Ethical Approval for this work was obtained from the Health Research Ethics Committee (HREC), Institute of Public Health, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria (IPHOAU/12/187).

Experimental Design, Induction of Gastric Lesion and Treatment {#sec2-3}
--------------------------------------------------------------

The rats were randomly assigned into 6 groups (A, B, C, D, E and F) of 15 rats each. At the commencement of the experiment, stool samples of each animal were obtained and tested for the presence of *H. pylori* antigen using the *H. pylori* Stool Antigen Test Kit (Biotech, China) as described by Olufemi *et al*. \[[@ref18]\].

Before the induction of gastric lesions, rats in the experimental group were starved overnight so as to ensure complete gastric emptying and a steady state gastric acid secretion. The animals were allowed free access to water during this period. Gastric lesions were induced in Groups B, C, D and E rats by a single oral administration of 400 mg/kg reference standard aspirin (Sigma Chemicals, USA) dissolved in 0.5 ml of distilled water. Group A rats received an equivalent volume of distilled water used in dissolving aspirin. Twenty-four hours later, flavonoid fraction of *M. paradisiaca* dissolved in distilled water was administered by gavage to the rats in groups C, D and E at graded doses of 100, 200 and 400 mg/kg respectively at a particular time (10.00-11.00 hours) for 21 days. Group F rats received Omeprazole (Divine Essential Formulations, Lagos, Nigeria) dissolved in distilled water at 1.8 mg/kg by gavage for 21 days. The rats in group A received equivalent volumes of distilled water used in dissolving the extract and drug for the same period.

On the 14^th^ and 21^st^ days of treatment, 5 rats from each group were sacrificed under ketamine anaesthesia at a dose of 75 mg/kg while the remaining were left untreated for another 7 days before sacrifice. Each of the animals was quickly dissected through a mid-line incision in the anterior abdominal wall.

Tissue Processing {#sec2-4}
-----------------

Samples of the gastric corpus in each group of animals were fixed in 10% neutral buffered formalin and processed according to the general technique of tissue processing and microtomy as described by Bancroft and Gamble \[[@ref19]\]. Sections of 4-5 µm thickness were produced on a Rotary microtome. Histopathology of gastric tissues was performed using Hematoxylin and Eosin (H&E); EGF receptor and PECAM-1 were localised using appropriate primary monoclonal antibodies respectively \[[@ref20], [@ref21]\].

Photomicrography and Image Analysis {#sec2-5}
-----------------------------------

The stained sections were examined under OMAX 40X-2000X Digital Light microscope. Digital photomicrographs of the tissue sections were taken at various magnifications.

The immunisation plugin in the Image J software was used to analyse and quantify areas of immunoreactivity in stained sections.

Determination of Ulcer Index {#sec2-6}
----------------------------

Microscopic ulcer index was obtained separately by two pathologists, and a mean index was calculated as described by Pandit *et al*. \[[@ref22]\].

Normal tissue = 0; Local damage to gastric pits cells = 1; Local damage to gastric glands = 2; Deep damage to gastric glands = 3.

Microscopic ulcer index = (number of lesion 1) + (number of lesion 2) × 2 + (number of lesion 3) ×3.

Statistical Analysis {#sec2-7}
--------------------

The results were expressed as mean ± SEM. Using the GraphPad Prism version 5.00 software, two-way ANOVA was used for comparative analysis of the data, followed by Bonferroni tests for multiple comparisons. Statistical significance was set at p \< 0.05.

Results {#sec1-3}
=======

Tests for Flavonoids in the Extract {#sec2-8}
-----------------------------------

Phytochemical analysis of the ethyl acetate fraction of *Musa paradisiaca* for the presence of flavonoid was positive as there was a coloration of red for the Shibata's reaction and bluish green for the Ferric chloride test respectively.

Ulcer Index of the Gastric Corpus of Control and Treated Rats {#sec2-9}
-------------------------------------------------------------

There was a significant difference in the ulcer index in the corpus of control and treated rats throughout the experimental period (p=0.0001). As seen in Table 1, in the gastric corpus, administration of aspirin resulted in a significant increase in ulcer index (p \< 0.05) in both group B and groups C, D and E when compared with the control. This indicates that aspirin-induced ulceration and hemorrhagic lesions in the gastric corpus of the rats that received it. On the 14^th^ and 21^st^ days of the experiment, there was a significant increase (p \< 0.05) in ulcer index in all the treated groups when compared with the control but on the 28^th^ day of the experiment, apart from the group C rats, there was no significant difference (p \> 0.05) in the ulcer index between the control and groups D, E and F rats. This indicates the efficacy of both MP (200 mg/kg and 400 mg/kg) and OMZ in the reduction of aspirin-induced gastric lesions over a period. Also, throughout the experimental period, a significant increase (p \< 0.05) was observed in the ulcer index of the group B rats when compared with all the treated groups (C, D, E and F). On the 14^th^ day of the experiment, there was no significant difference (p \< 0.05) in ulcer index among the treated groups of rats (C, D, E and F). At the end of the treatment period, a significant increase (p \< 0.05) was however observed when group C was compared with groups D, E and F. This shows the efficacy of *MP* at doses of 200 mg/kg, 400 mg/kg and OMZ over *MP* at doses of 100 mg/kg in reducing the ulcer index.

Histological Observation of the Gastric Corpus {#sec2-10}
----------------------------------------------

On day 14 of the experimental period, as seen in [Fig. 1](#F1){ref-type="fig"}, the gastric corpus of group A presented with a normal histoarchitecture characterised by a well-organized outline of the gastric layers. A continuous epithelial lining was also observed. In group B, there was discontinuation of the epithelial lining as evidenced by the ulcer craters. In the treated groups, a gradual restoration of the epithelial lining was observed. Groups D and E presented with a proper alignment of the connective tissue fibres similar to what is observable in control. However, some pockets of ulcerations were still observed in groups C and F. As seen in [Fig. 2](#F2){ref-type="fig"}, on Day 21, the control group displayed a well-structured histoarchitecture with the gastric layers well arranged. In group B, there were severe ulcerations as characterised by epithelial distortions. Evidence of distortion of the connective tissue fibres within the mucosa was also observed. The treated groups displayed a normal histoarchitecture as compared with the control. No ulcerations were observed, and the gastric layers were in proper alignment.

![Photomicrograph of the Gastric Corpus of Control (A), ASA Only (B), MP Treated (C, D, E) and OMZ Treated (F) Groups on Day 14. H&E, X100. Mucosa (M), Muscularis mucosa (arrows), Submucosa (SM), Muscular propia (MP), Ulcer crater (dashed arrow)](OAMJMS-5-569-g001){#F1}

![Photomicrograph of the Gastric Corpus of Control (A), ASA Only (B), MP Treated (C, D, E) and OMZ Treated (F) Groups on Day 21. H&E, X100. Mucosa (M), Muscularis mucosa (arrows), Submucosa (SM), Muscularis propia (MP), Ulcer crater (dashed arrow)](OAMJMS-5-569-g002){#F2}

On Day 28, a well-organized histoarchitecture was observed in the gastric layers of the control and treated groups. Group B, however, showed severe ulceration with irregularly arranged connective tissue fibres in the submucosa ([Fig. 3](#F3){ref-type="fig"}).

![Photomicrograph of the Gastric Corpus of Control (A), ASA Only (B), MP Treated (C, D, E) and OMZ Treated (F) Groups on Day 28. H&E, X100. Mucosa (M), Muscularis mucosa (arrows), Submucosa (SM), Muscularis propia (MP), Ulcer crater (dashed arrow)](OAMJMS-5-569-g003){#F3}

Epidermal Growth Factor Receptor (EGFR) {#sec2-11}
---------------------------------------

On days 14, 21 and 28 of the study, immunohistochemical staining of the granulation tissue and ulcer margin of the gastric mucosal of rats in group B did not display significant immunoreactivity for EGFR ([Fig. 4B](#F4){ref-type="fig"}, [5B](#F5){ref-type="fig"}, [6B](#F6){ref-type="fig"}).

![Expression of EGFR (brown colour) in the Gastric Corpus of Control (A), ASA Only (B), MP Treated (C, D, E) and OMZ Treated (F) Groups on Day 14 Note the EGFR immunoreactivity in the treatment groups. X400](OAMJMS-5-569-g004){#F4}

![Expression of EGFR (brown colour) in the Gastric Corpus of Control (A), ASA Only (B), MP Treated (C, D, E) and OMZ Treated (F) Groups on Day 21. Note the EGFR immunoreactivity in the control and treatment groups. X400](OAMJMS-5-569-g005){#F5}

![Expression of EGFR (brown colour) in the Gastric Corpus of Control (A), ASA Only (B), MP Treated (C, D, E) and OMZ Treated (F) Groups on Day 28. Note the EGFR immunoreactivity in the control and treatment groups. X400](OAMJMS-5-569-g006){#F6}

When compared with the control, the treated groups (C, D, E and F) displayed a significant EGFR immunoreactivity ([Fig. 4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}).

Quantitative Analysis of EGFR Positive Cells in the Gastric Corpus of Control and Treated Rats {#sec2-12}
----------------------------------------------------------------------------------------------

Using the Image J immunisation analysis tool, immunohistochemical studies of the gastric body showed that there was a significant difference in the number of EGFR positive cells among groups A to F on days 14, 21 and 28 (p = 0.0001). There was no significant difference (p \> 0.05) in the number of EGFR positive cells in group B compared with the control ([Fig. 7](#F7){ref-type="fig"}). In contrast, all the treatment groups had a significantly increased (p \< 0.01) number of EGFR positive cells when compared with control throughout the experimental period. Similar findings were made when group B was compared with all the treatment groups as there was a significant increase (p \< 0.05) in the number of EGFR immunoreactive cells in the treatment groups.

![Immunization Plugging Analysis of EGFR Positive Cells in the Gastric Corpus of Control and Treated rats. \*p \< 0.05. α and β - significant difference compared to control and group B respectively](OAMJMS-5-569-g007){#F7}

On the 21^st^ and 28^th^ days of the experiment, there was a significant increase (p \< 0.05) in the number of EGFR positive cells in groups D and E when compared with group C. This indicates a better healing effect of MP in groups D and E when compared with group C. At the end of the experimental period, there was no significant difference (p \> 0.05) in the number of EGFR immunoreactive cells between groups C and F. Also; there was no significant difference (p \> 0.05) between the number of EGFR immunoreactive cells in groups D and E throughout the experimental period. This indicates similar healing effects of MP at the dose of 200 mg/kg and 400 mg/kg. As seen in [figure 1](#F1){ref-type="fig"}, group E had a significantly increased (p \< 0.05) number of EGFR immunoreactive cells when compared with group F at the end of the experimental period.

PECAM-1 Immunohistochemistry {#sec2-13}
----------------------------

Immunohistochemical staining of the gastric mucosal tissue of rats in group B did not display significant immunoreactivity for PECAM-1 ([Fig 8B](#F8){ref-type="fig"}, [9B](#F9){ref-type="fig"}, [10B](#F10){ref-type="fig"}).

![Expression of PECAM-1 (brown colour) in the Gastric Corpus of Control (A), ASA Only (B), MP Treated (C, D, E) and OMZ Treated (F) Groups on Day 14. X400](OAMJMS-5-569-g008){#F8}

![Expression of PECAM-1 (brown colour) in the Gastric Corpus of Control (A), ASA Only (B), MP Treated (C, D, E) and OMZ Treated (F) Groups on Day 21. X400](OAMJMS-5-569-g009){#F9}

![Expression of PECAM-1 (brown colour) in the Gastric Corpus of Control (A), ASA Only (B), MP Treated (C, D, E) and OMZ Treated (F) Groups on Day 28. X400](OAMJMS-5-569-g010){#F10}

When compared with the control, the treated groups (C, D, E and F) displayed a significant PECAM-1 immunoreactivity ([Fig 8](#F8){ref-type="fig"}, [9](#F9){ref-type="fig"}, [10](#F10){ref-type="fig"}). There was little or no staining for PECAM-1 in the gastric tissues of the control group.

Quantitative Analysis of PECAM-1 Positive Cells in Gastric Corpus of Control and Treated Rats {#sec2-14}
---------------------------------------------------------------------------------------------

In the gastric corpus, Image J immunisation analysis tool showed that there was a significant difference in the number of PECAM-1 immunoreactive cells throughout the experimental period (p = 0.0001). There was no significant difference (p \> 0.05) in the number of PECAM-1 positive cells between the control and group B ([Fig. 11](#F11){ref-type="fig"}).

![Immunization Plugging Analysis of PECAM-1 Positive Cells in Corpus of Control and Treated Rats. \*p \< 0.05, α and β - significant difference compared to control and group B respectively](OAMJMS-5-569-g011){#F11}

This indicates a delay in the process of angiogenesis. In contrast, throughout the experimental period, there was a significant increase (p \< 0.05) in the number of PECAM-1 positive cells in the treatment groups (C, D, E and F) when compared with the control. This shows the restoration of microvessels in the treatment groups.

In groups C, D, E and F, there was a significant increase (p \< 0.05) in the number of PECAM-1 positive cells when compared with group B. The reduced rate of angiogenesis and hence the effectiveness of healing was also observed as there was a significant difference in the number of PECAM-1 positive cells between group C and groups D, E and F on days 21 and 28 of the experimental period. However, there was no significant difference in the number of PECAM-1 positive cells among the other treatment groups.

Discussion {#sec1-4}
==========

Many growth factors including Epidermal Growth Factor (EGF) contribute to the mechanism of ulcer healing as a result of the stimulatory effect on the process of mucosal repair, cell migration and proliferation as well as angiogenesis. Konturek et al. \[[@ref23]\] observed that EGF which is normally present in saliva and gastric juice exerts potent mitogenic and gastroprotective activities. EGFR enhances proliferation which is important for ulcer healing as it supplies essential epithelial cells for re-epithelization of mucosa surface and reconstruction of gastric gland. Results from this study show that in the gastric corpus, the number of EGFR positive cells in the treatment groups significantly increased when compared with control and the ASA only groups throughout the experimental period. Recent research indicated that EGFR was closely related to the healing of impaired gastric mucosa and was of great importance in gastric mucosal protection \[[@ref24], [@ref25]\]. Other studies indicated that there was an elevated EGFR expression during the healing course of damaged gastric mucosa \[[@ref25], [@ref27]\]. The observed effect on the expression of EGFR in *MP*-treated groups was however in a dose-dependent manner. There was a significantly increased expression of EGFR in the gastric tissues of rats treated with MP~200~ and MP~400~ when compared with MP~100~. This shows the efficacy of MP~200~ and MP~400~ over MP~100~ in the healing of gastric ulcers. A comparable effect was also observed in the expression of EGFR between MP~100~ and OMZ groups as there was no significant difference in EGFR expression in both groups at the end of the experimental period. Several studies have shown that in gastric mucosa of the ulcer margin, epithelial cells form a characteristic "recovery zone" and dilated gastric glands undergo differentiation and express EGFR \[[@ref24], [@ref28]\]. In another study, following aspirin-induced gastric damage, fucoidan-treated rats demonstrated significant EGFR immunoreactivity around the submucosal connective tissue \[[@ref20]\]. The present study complements those above.

Results from this study showed a significantly reduced expression of EGFR in the ASA only group when compared with the treatment groups. Suppression of endogenous NO synthesis leads to delayed ulcer healing and high doses of aspirin impair normal NO activity, thereby suppressing the expression of growth factors (such as EGFR) in ulcer progression \[[@ref29]\]. In another study, aspirin-treated rats showed a weak positive EGFR immunoreactive signal, confirming that EGF produced locally activate re-epithelialization and migration of epithelial cells from the ulcer margin to restore mucosal epithelial continuity.

PECAM- 1 is an endothelial marker involved in cell adhesion and angiogenesis \[[@ref30]\]. The nsaids-induced gastric injury is associated with vascular changes that cause hypoxia in the mucosa and activation of leukocytes \[[@ref31]\]. Konturek *et al*. \[[@ref32]\] noted that impairment in gastric blood flow (GBF) at an ulcer area and excessive cytokine expression and release, as well as a reduction in the mucosal antioxidizing enzyme activity induced by NSAIDs, may contribute to the delay in ulcer healing. When there is damage to the vascular endothelium, the decreased blood flow which reduces oxygen supply and consequently the nutrient transport results in the appearance of erosion and ulceration in the mucous membrane \[[@ref33]\].

In this study, throughout the experimental period, there was a significantly increased PECAM-1 immunoreactivity in the corpus when the treated groups were compared with control. Remodelling of the destroyed vascular network within the ulcerated site is integral to healing. A reduced efficacy of MP~100~ in angiogenesis was observed as there was a significant reduction in PECAM-1 immunoreactivity between MP~100~ and the other treatment groups. In the ASA only group, there was a significant reduction in the PECAM-1 immunoreactivity when compared with the treated groups. However, there was a significant increase in PECAM-1 immunoreactivity in MP~200~ and MP~400~ groups when compared with MP~100~ groups. This indicates the ability of *MP* to initiate angiogenesis in impaired gastric tissues at 200 mg/kg and 400 mg/kg. The delay in gastric ulcer healing with ASA administration has been associated with diminished angiogenesis and impaired blood flow at the ulcer margin \[[@ref34], [@ref35]\]. Results from this study showed that a marked reduction in immunoreactivity to PECAM-1 was observed in the ASA only group. Our results are in agreement with the work of Hudson *et al*. \[[@ref36]\] who investigated the relationship between NSAID therapy and gastroduodenal ulcer healing.

In conclusion, this study have demonstrated that oral administration of flavonoid fraction of mature and unripe fruit extract of *MP* at a dose of 200 mg/kg and 400 mg/kg significantly (compared with placebo and omeprazole) attenuated the damaging effects of aspirin on the gastric mucosa as it enhances expression of EGFR and PECAM-1.

At these doses, results obtained for *MP* was better than OMZ. Omeprazole is used for the treatment of gastric ulcers due to its ability to irreversibly inhibit the H^+^/K^+^/ATPase pump. In this study, *MP* was efficacious in restoring the integrity of the damaged mucosa by increasing the expression of EGFR and PECAM-1. Activation of these markers appears to promote gastric ulcer healing, thereby facilitating tissue repair.

Despite the fact that *MP* has been found to have a stimulatory effect on mucosa growth, clinical studies in human are needed to provide evidence of its efficacy and explore the potential of development of leads that may contribute to drug development.
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